Le Lézard
Classified in: Health
Subjects: PDT, MAT

Djot, the "Keurig of cannabis" unveils newest Djot Dispenser design with stylish, functional features for precise and discreet cannabis dosing


The sleek, new Djot Dispenser will launch Q1 of 2023  

TORONTO, Oct. 4, 2022 /CNW/ - Innovative Canadian tech startup, Djot, unveiled today the latest design of its industry-leading Djot Dispenser; the newly-designed dispensing technology delivers personalized and precise cannabis dosing at the touch of a button.

The patented Djot Dispenser, dubbed the "Keurig of cannabis" precisely delivers doses of one to 10mg of water-soluble THC and CBD concentrate into any beverage for a truly tailored cannabis experience. The disruptive technology eliminates concerns of smoke and vapour inhalation and offers added discretion for health and wellness consumers.

The latest Djot Dispenser design features new sleek, bevelled contours with a larger display screen, streamlined button functionality, ergonomic rubber casing, and safety passcode. The easy-to-use device is complete with new light indicators displaying when the device is calibrated and ready to use.

"Working with a boutique industrial design company, we wanted to take our innovative technology and execute it in a way that elevates the overall consumer experience to best-in-class," said Elad Barak, CEO of Djot.  "The new design is sleek and ergonomic, fitting nicely in your hand, pocket or purse. It features a large colour screen with a comfortable silicone grip cover."

The Djot Dispenser is set to launch in Q1 of 2023. For more information, please visit www.Djot.com.            

About Djot

With funding led by tech venture capital firm Draper Cygnus, Djot is a Toronto-based company operating in the health tech sector, co-founded in 2019 by Canadian entrepreneurs Elad Barak and Arjen Melis.

Funding for their industry-leading product launch is closing shortly. If you're interested in getting involved, please contact [email protected].

Available for interviews:
Elad Barak, Co-Founder and CEO of Djot
Arjen Melis, Co-Founder and President of Djot

SOURCE Djot


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: